Jinshiya Pharmaceutical (300434.SZ): The sustained-release tablets of sodium diclofenac have passed the consistency evaluation.

Wisdom Finance News APP, Jinshi Ya Medicine (300434.SZ) announced that its wholly-owned subsidiary, Zhejiang Di'er Pharmaceutical Co., Ltd. (referred to as "Di'er Pharmaceutical"), recently received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration. Di'er Pharmaceutical's diclofenac sodium sustained-release tablets (0.1g specification) passed the evaluation of generic drug quality and efficacy consistency.